Literature DB >> 1362142

Polymerase chain reaction and its potential as a pharmacokinetic tool.

M H Heim1.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1362142     DOI： 10.2165/00003088-199223050-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  34 in total

Review 1.  Recent advances in the polymerase chain reaction.

Authors:  H A Erlich; D Gelfand; J J Sninsky
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

2.  Genetic analysis of cytochrome P450 system.

Authors:  N K Spurr; A C Gough; C A Smith; C R Wolf
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

3.  Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification.

Authors:  M Heim; U A Meyer
Journal:  Lancet       Date:  1990-09-01       Impact factor: 79.321

Review 4.  DNA polymorphism and human disease.

Authors:  J F Gusella
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

Review 5.  Methyltransferase pharmacogenetics.

Authors:  R Weinshilboum
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

6.  Molecular mechanism of slow acetylation of drugs and carcinogens in humans.

Authors:  M Blum; A Demierre; D M Grant; M Heim; U A Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

Review 7.  Phenytoin: pharmacogenetic polymorphism of 4'-hydroxylation.

Authors:  T Inaba
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

8.  Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form.

Authors:  B Bertocci; V Miggiano; M Da Prada; Z Dembic; H W Lahm; P Malherbe
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

9.  N-acetyltransferase polymorphism. Comparison of phenotype and genotype in humans.

Authors:  D Hickman; E Sim
Journal:  Biochem Pharmacol       Date:  1991-08-08       Impact factor: 5.858

10.  Lung cancer and the debrisoquine metabolic phenotype.

Authors:  N E Caporaso; M A Tucker; R N Hoover; R B Hayes; L W Pickle; H J Issaq; G M Muschik; L Green-Gallo; D Buivys; S Aisner
Journal:  J Natl Cancer Inst       Date:  1990-08-01       Impact factor: 13.506
View more
  1 in total

Review 1.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.